Global NASH/MASH Council and Global Liver Council at AASLD 2026

Heading to Denver for The Liver Meeting 2026 (AASLD, November 5–9) The Global NASH/MASH Council (GNC), together with The Global Liver Council (GLC), is proud to share that our members and collaborators will contribute 29 presentations at this year's meeting: 2 invited lectures, 4 oral presentations, 4 posters of distinction, 17 posters and 2 SIG poster highlights. This year's program reflects the breadth of our shared research agenda. Our work spans MASLD and MASH epidemiology and outcomes, non-invasive risk stratification in primary care, and patient-reported outcomes, including the newly developed CLDQ-MASH Symptom Questionnaire. It also extends to genetic risk in a global cohort, the economic burden of MASH, alcohol-related liver disease, hepatitis B, and two decades of liver transplantation data from the United States and Europe. Among the highlights, the invited lectures will address obesity as a multisystem liver disease and the epidemiology of steatotic liver disease. The oral presentations will examine MASH overtaking alcohol-associated liver disease as the main driver of rising liver cancer linked to steatotic liver disease, validate sequential FIB-4, VCTE and ELF testing to detect advanced fibrosis in U.S. primary care, use of PEth testing to uncover hidden alcohol exposure in MASLD, and explore sex-specific outcomes among liver transplant candidates and recipients. Behind every one of these presentations is a global network of investigators. Our collaborators bring together diverse disciplines, regions and shared data, making possible the kind of large-scale, high-impact studies that no single center could achieve alone. We are deeply grateful to every investigator, co-author and patient whose contributions made this global effort possible. The full schedule, with dates, times and publication numbers, is in the slides below. If you are in Denver, please stop by our posters or join one of our sessions. We look forward to seeing you and continuing the conversation on how we can improve liver health worldwide.